Latest filing published 14 Jun 2017 for Adverum Biotechnologies, Inc..
Insider track record
No signal scores available.
Richard N. Spivey: trading record in brief
Richard N. Spivey discloses dealings in Adverum Biotechnologies, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 19 April 2017 to 12 June 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 14 June 2017 came the latest disclosure, a share grant in Adverum Biotechnologies, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard N. Spivey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,727 shares0Common StockSEC:0001209191-17-039968:0
- 48,077 shares0Common StockSEC:0001209191-17-027841:0
2 of 2 declarations